Estimated Control Closed Transaction verified SupplementsConsumer Health

Biogix, Inc. acquired by Alliance Pharma plc

Alliance Pharma plc acquired Biogix, Inc., a vitamins & supplements brand, on Dec 29, 2020.

Transaction summary

Target
Biogix, Inc.
Seller
-
Announced
2020-12-29
Completed
2020-12-29
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-13
Latest update
2026-11-01

Value and multiples

100% enterprise value

USD 110M

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

5x

Period: FY2019

Basis: Derived from source data

EV / EBITDA

15.7x

EBITDA: normalised / adjusted

Basis: Derived from source data

Basis

  • Alliance Pharma bought Biogix, which sells Amberen menopause relief products, on 29 December 2020 for US$110m in cash plus customary adjustments. Audited FY2019 sales of US$22m give 5.0x revenue. Expected FY2020 management-adjusted EBITDA of about US$7m gives 15.7x EBITDA. The revenue and EBITDA periods differ; forecast annualised 2020 sales were about US$27m.

Source summary

Alliance Pharma plc: Acquisition of Biogix Inc

Confirmed

it has today completed the acquisition of 100% of the share capital of Biogix Inc

Open source

Alliance Pharma plc: Acquisition of Biogix Inc

Confirmed

a management-adjusted EBITDA expected to be approximately US$7 million

Open source

Thorne HealthTech Schedule 14D-9/A

Estimated

Canaccord Genuity's selected precedent transactions (US$ in millions) list December 2020, Alliance Pharma plc and Biogix, Inc.: implied TEV $110, TEV / LTM Adjusted EBITDA 15.7x.

Open source

Continue your research

Explore more comps →